Impact of Olanzapine on Human Lipid Profiles: A Meta-Analysis of Randomized Controlled Trials Considering Time and Dosage Responses - Top-Institutions - MDSpire

Impact of Olanzapine on Human Lipid Profiles: A Meta-Analysis of Randomized Controlled Trials Considering Time and Dosage Responses

  • By

  • Zhou Fang

  • Parmida Jamilian

  • Mohammad Safargar

  • Kousalya Prabahar

  • Liu Shuang

  • January 6, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    National Institute of Mental Health (NIMH)
    National Institute of Mental Health (NIMH)

    Bethesda, MD

    Key Differentiators

    • Psychiatry
    • Pharmacology
    • Metabolic Research

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Psychiatry
    • Endocrinology
    • Cardiology

  • #3

    Massachusetts General Hospital (MGH) / Harvard Medical School
    Massachusetts General Hospital (MGH) / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Psychiatry
    • Pharmacology
    • Lipidology

  • #4

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Psychiatry
    • Pharmacology
    • Cardiovascular Medicine

  • #5

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Psychiatry
    • Endocrinology
    • Clinical Pharmacology

Original Source(s)

Impact of Olanzapine on Human Lipid Profiles: A Meta-Analysis of Randomized Controlled Trials Considering Time and Dosage Responses

  • by Zhou Fang, Parmida Jamilian, Mohammad Safargar, Kousalya Prabahar, Liu Shuang

  • January 6, 2026

Related Content

The relationship between the triglyceride-glucose index and serum uric acid levels: a systematic review and meta-analysis

Chronotropic incompetency during stress echocardiography: a new paradigm for mortality and cardiac event prediction?

Erythrocyte odd-chain fatty acids and the risk of cardiometabolic diseases: a prospective study and updated meta-analysis